Form 4 for VATE INNOVATE Corp.
Accepted 2024-10-30 00:00:00 ET · period of report 2024-10-29 · accession 0001006837-24-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-30 | 2024-10-29 | VATE | Voigt Paul | Interim CEO | A - Grant | $0.00 | +238.2K | 307.0K | +346% | $0 |
| DM | 2024-10-30 | 2024-10-29 | VATE | Voigt Paul | Interim CEO | A - Grant | $0.00 | +200.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-29 | A | A | 142,857 | $0.00 | 449,834 | D | — | — | (F2) The RSU was granted on August 19, 2024, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024. |
| 2 | Common | Common Stock | 2024-10-29 | A | A | 95,322 | $0.00 | 306,977 | D | — | — | (F1) The restricted stock unit award (the "RSU") was granted on October 11, 2023, subject to stockholder approval of an amendment to the Second Amended and Restated 2014 Omnibus Equity Award Plan (the "Second A&R 2014 Plan") to increase the number of shares of Common Stock available thereunder to satisfy the settlement of the grant (the "Share Approval Condition"), which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024. |
| 3 | Derivative | Stock option (Right To Buy) | 2024-10-29 | A | A | 100,000 | $0.00 | 100,000 | D | $25.00 · 2024-10-29 to 2033-09-15 | 100,000 Common Stock | (F5) The option award was granted on September 15, 2023, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024. (F6) The reported shares have been retroactively adjusted to reflect the 1-for-10 reverse split of the Issuer's Common Stock effective as of August 8, 2024. (F4) The option award was granted with an exercise price of $25.00 per share (retroactively adjusted to reflect the 1-for-10 reverse split of the Common Stock effective as of August 8, 2024), which price was greater than the fair market value per share on the date of the grant. |
| 4 | Derivative | Stock option (Right To Buy) | 2024-10-29 | A | A | 100,000 | $0.00 | 100,000 | D | $4.22 · 2025-09-15 to 2034-09-15 | 100,000 Common Stock | (F8) The option award was granted on September 15, 2024, subject to the Share Approval Condition, which was approved by the stockholders on October 4, 2024 effective as of October 29, 2024. (F7) The option award was granted on September 15, 2024 with an exercise price to be set at 110% of the 10-day VWAP on the date of the grant. |